home All News open_in_new Full Article

Stock in Tylenol’s parent company rallies after Trump’s unproven claims

Tylenol's parent company, Kenvue, saw its stock price rebound in premarket trading on Tuesday after U.S. President Donald Trump made unfounded claims about the drug.


today 1 week ago attach_file Economics

attach_file Other
attach_file Culture
attach_file Economics
attach_file Economics
attach_file Technology
attach_file Economics
attach_file Other
attach_file Other
attach_file Economics


ID: 379900574
Add Watch Country

arrow_drop_down